Published in Nucleic Acids Res on August 03, 2009
A diverse range of gene products are effectors of the type I interferon antiviral response. Nature (2011) 12.86
RNA editing in the human ENCODE RNA-seq data. Genome Res (2012) 2.18
Molecular diversity through RNA editing: a balancing act. Trends Genet (2010) 1.98
Nature, position, and frequency of mutations made in a single cycle of HIV-1 replication. J Virol (2010) 1.65
Adenosine deaminases acting on RNA (ADARs) are both antiviral and proviral. Virology (2011) 1.62
NEAT1 long noncoding RNA and paraspeckle bodies modulate HIV-1 posttranscriptional expression. MBio (2013) 1.55
RNA-specific adenosine deaminase ADAR1 suppresses measles virus-induced apoptosis and activation of protein kinase PKR. J Biol Chem (2009) 1.53
Mouse SAMHD1 has antiretroviral activity and suppresses a spontaneous cell-intrinsic antiviral response. Cell Rep (2013) 1.28
Enhancement of replication of RNA viruses by ADAR1 via RNA editing and inhibition of RNA-activated protein kinase. J Virol (2011) 1.16
Protein kinase PKR and RNA adenosine deaminase ADAR1: new roles for old players as modulators of the interferon response. Curr Opin Immunol (2011) 1.15
Adenosine deaminases acting on RNA, RNA editing, and interferon action. J Interferon Cytokine Res (2010) 1.11
Human immunodeficiency virus reverse transcriptase displays dramatically higher fidelity under physiological magnesium conditions in vitro. J Virol (2014) 1.09
RNA adenosine deaminase ADAR1 deficiency leads to increased activation of protein kinase PKR and reduced vesicular stomatitis virus growth following interferon treatment. Virology (2009) 1.03
Adenosine deaminase acting on RNA 1 (ADAR1) suppresses the induction of interferon by measles virus. J Virol (2012) 1.02
Characterization of staufen1 ribonucleoproteins by mass spectrometry and biochemical analyses reveal the presence of diverse host proteins associated with human immunodeficiency virus type 1. Front Microbiol (2012) 0.92
Variation of HIV-1 mutation spectra among cell types. J Virol (2013) 0.90
ADARs: viruses and innate immunity. Curr Top Microbiol Immunol (2012) 0.89
Adenosine deaminase acting on RNA 1 limits RIG-I RNA detection and suppresses IFN production responding to viral and endogenous RNAs. J Immunol (2014) 0.88
Substitutional A-to-I RNA editing. Wiley Interdiscip Rev RNA (2011) 0.88
ADAR1 is a novel multi targeted anti-HIV-1 cellular protein. Virology (2011) 0.86
An RNA editor, adenosine deaminase acting on double-stranded RNA (ADAR1). J Interferon Cytokine Res (2014) 0.86
The PKR activator, PACT, becomes a PKR inhibitor during HIV-1 replication. Retrovirology (2013) 0.86
The genetic basis for individual differences in mRNA splicing and APOBEC1 editing activity in murine macrophages. Genome Res (2013) 0.86
Mouse models for Aicardi-Goutières syndrome provide clues to the molecular pathogenesis of systemic autoimmunity. Clin Exp Immunol (2014) 0.84
Passage of a Sendai virus recombinant in embryonated chicken eggs leads to markedly rapid accumulation of U-to-C transitions in a limited region of the viral genome. PLoS One (2012) 0.80
ADAR1 enhances HTLV-1 and HTLV-2 replication through inhibition of PKR activity. Retrovirology (2014) 0.78
ADAR1 Facilitates HIV-1 Replication in Primary CD4+ T Cells. PLoS One (2015) 0.78
Hyperediting of human T-cell leukemia virus type 2 and simian T-cell leukemia virus type 3 by the dsRNA adenosine deaminase ADAR-1. J Gen Virol (2012) 0.77
HIV-1 infection causes a down-regulation of genes involved in ribosome biogenesis. PLoS One (2014) 0.77
The emerging role of long non-coding RNAs in HIV infection. Virus Res (2015) 0.77
Making the Mark: The Role of Adenosine Modifications in the Life Cycle of RNA Viruses. Cell Host Microbe (2017) 0.76
Adenosine deaminase acting on RNA-1 (ADAR1) inhibits HIV-1 replication in human alveolar macrophages. PLoS One (2014) 0.76
Interferon-inducible LY6E Protein Promotes HIV-1 Infection. J Biol Chem (2017) 0.75
Functions of the RNA Editing Enzyme ADAR1 and Their Relevance to Human Diseases. Genes (Basel) (2016) 0.75
Incorporating alternative splicing and mRNA editing into the genetic analysis of complex traits. Bioessays (2014) 0.75
ADAR1 restricts LINE-1 retrotransposition. Nucleic Acids Res (2016) 0.75
Diverse selective regimes shape genetic diversity at ADAR genes and at their coding targets. RNA Biol (2015) 0.75
NF45 and NF90 Bind HIV-1 RNA and Modulate HIV Gene Expression. Viruses (2016) 0.75
Cellular, physiological and pathological aspects of the long non-coding RNA NEAT1. Front Biol (Beijing) (2016) 0.75
Single-Strand Consensus Sequencing Reveals that HIV Type but not Subtype Significantly Impacts Viral Mutation Frequencies and Spectra. J Mol Biol (2017) 0.75
RNA editing by adenosine deaminases that act on RNA. Annu Rev Biochem (2001) 9.66
Systematic identification of abundant A-to-I editing sites in the human transcriptome. Nat Biotechnol (2004) 7.61
Widespread A-to-I RNA editing of Alu-containing mRNAs in the human transcriptome. PLoS Biol (2004) 6.67
Widespread RNA editing of embedded alu elements in the human transcriptome. Genome Res (2004) 5.14
Regulation of alternative splicing by RNA editing. Nature (1999) 5.00
The APOBEC3 cytidine deaminases: an innate defensive network opposing exogenous retroviruses and endogenous retroelements. Annu Rev Immunol (2008) 4.27
Expression and regulation by interferon of a double-stranded-RNA-specific adenosine deaminase from human cells: evidence for two forms of the deaminase. Mol Cell Biol (1995) 4.12
RNA editing of hepatitis delta virus antigenome by dsRNA-adenosine deaminase. Nature (1996) 4.04
Editor meets silencer: crosstalk between RNA editing and RNA interference. Nat Rev Mol Cell Biol (2006) 3.31
Underediting of glutamate receptor GluR-B mRNA in malignant gliomas. Proc Natl Acad Sci U S A (2001) 3.14
A third member of the RNA-specific adenosine deaminase gene family, ADAR3, contains both single- and double-stranded RNA binding domains. RNA (2000) 3.06
A 19-nucleotide sequence upstream of the 5' major splice donor is part of the dimerization domain of human immunodeficiency virus 1 genomic RNA. Biochemistry (1994) 3.05
Quantitative detection of HIV-1 drug resistance mutations by automated DNA sequencing. Nature (1993) 2.86
Cloning of cDNAs encoding mammalian double-stranded RNA-specific adenosine deaminase. Mol Cell Biol (1995) 2.66
RED2, a brain-specific member of the RNA-specific adenosine deaminase family. J Biol Chem (1996) 2.64
The many roles of an RNA editor. Nat Rev Genet (2001) 2.55
Hepatitis D virus RNA editing: specific modification of adenosine in the antigenomic RNA. J Virol (1995) 2.54
A new reporter cell line to monitor HIV infection and drug susceptibility in vitro. Proc Natl Acad Sci U S A (1997) 2.52
Synthetic polynucleotides and the amino acid code. V. Proc Natl Acad Sci U S A (1962) 2.01
Q/R site editing in kainate receptor GluR5 and GluR6 pre-mRNAs requires distant intronic sequences. Proc Natl Acad Sci U S A (1996) 1.92
A hairpin structure in the R region of the human immunodeficiency virus type 1 RNA genome is instrumental in polyadenylation site selection. J Virol (1999) 1.91
A conserved hairpin motif in the R-U5 region of the human immunodeficiency virus type 1 RNA genome is essential for replication. J Virol (1997) 1.91
Two forms of human double-stranded RNA-specific editase 1 (hRED1) generated by the insertion of an Alu cassette. RNA (1997) 1.83
New antiviral pathway that mediates hepatitis C virus replicon interferon sensitivity through ADAR1. J Virol (2005) 1.78
Host factors influencing susceptibility to HIV infection and AIDS progression. Retrovirology (2007) 1.77
Down-regulation of RNA editing in pediatric astrocytomas: ADAR2 editing activity inhibits cell migration and proliferation. J Biol Chem (2008) 1.71
Widespread inosine-containing mRNA in lymphocytes regulated by ADAR1 in response to inflammation. Immunology (2003) 1.67
Biased (A-->I) hypermutation of animal RNA virus genomes. Curr Opin Genet Dev (1994) 1.65
Human immunodeficiency virus 1 Nef protein downmodulates the ligands of the activating receptor NKG2D and inhibits natural killer cell-mediated cytotoxicity. J Gen Virol (2007) 1.63
Interferon action and the double-stranded RNA-dependent enzymes ADAR1 adenosine deaminase and PKR protein kinase. Prog Nucleic Acid Res Mol Biol (2006) 1.62
HIV-1 TAR RNA: the target of molecular interactions between the virus and its host. Curr HIV Res (2005) 1.56
ADAR1 interacts with NF90 through double-stranded RNA and regulates NF90-mediated gene expression independently of RNA editing. Mol Cell Biol (2005) 1.49
Tat-dependent adenosine-to-inosine modification of wild-type transactivation response RNA. Proc Natl Acad Sci U S A (1991) 1.35
Transcriptional and post-transcriptional regulation of HIV-1 gene expression: role of cellular factors for Tat and Rev. Future Microbiol (2006) 1.32
Identification of Staufen in the human immunodeficiency virus type 1 Gag ribonucleoprotein complex and a role in generating infectious viral particles. Mol Cell Biol (2004) 1.31
Double-stranded RNA deaminase ADAR1 increases host susceptibility to virus infection. J Virol (2006) 1.29
The regulation of human immunodeficiency virus type-1 gene expression. Eur J Biochem (1996) 1.25
A-to-G hypermutation in the genome of lymphocytic choriomeningitis virus. J Virol (2006) 1.18
Double-stranded RNA adenosine deaminases enhance expression of human immunodeficiency virus type 1 proteins. J Virol (2008) 1.13
Insights into the selective activation of alternatively used splice acceptors by the human immunodeficiency virus type-1 bidirectional splicing enhancer. Nucleic Acids Res (2008) 0.99
Structural differentiation of the HIV-1 polyA signals. J Biomol Struct Dyn (2006) 0.96
Transcript mutations of the alpha regulatory subunit of protein kinase A and up-regulation of the RNA-editing gene transcript in lupus T lymphocytes. Lancet (2002) 0.96
CD4 and major histocompatibility complex class I downregulation by the human immunodeficiency virus type 1 nef protein in pediatric AIDS progression. J Virol (2003) 0.92
Altered editing in RNA editing adenosine deaminase ADAR2 gene transcripts of systemic lupus erythematosus T lymphocytes. Immunology (2007) 0.88
Genetic changes in hepatitis delta virus from acutely and chronically infected woodchucks. J Virol (2006) 0.86
Kinetics of formation of hypoxanthine containing base pairs by HIV-RT: RNA template effects on the base substitution frequencies. Nucleic Acids Res (2001) 0.79
Regulation of the p27(Kip1) tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferation. EMBO J (2007) 6.26
miR-221 and miR-222 expression affects the proliferation potential of human prostate carcinoma cell lines by targeting p27Kip1. J Biol Chem (2007) 5.02
Inhibition of HIV-1 infection by lentiviral vectors expressing Pol III-promoted anti-HIV RNAs. Mol Ther (2003) 1.82
Down-regulation of RNA editing in pediatric astrocytomas: ADAR2 editing activity inhibits cell migration and proliferation. J Biol Chem (2008) 1.71
Human immunodeficiency virus 1 Nef protein downmodulates the ligands of the activating receptor NKG2D and inhibits natural killer cell-mediated cytotoxicity. J Gen Virol (2007) 1.63
The inhibition of the highly expressed miR-221 and miR-222 impairs the growth of prostate carcinoma xenografts in mice. PLoS One (2008) 1.56
MiR-128 up-regulation inhibits Reelin and DCX expression and reduces neuroblastoma cell motility and invasiveness. FASEB J (2009) 1.51
Tuning of RNA editing by ADAR is required in Drosophila. EMBO J (2005) 1.39
Systematic identification of edited microRNAs in the human brain. Genome Res (2012) 1.35
A-to-I RNA editing: the "ADAR" side of human cancer. Semin Cell Dev Biol (2011) 1.19
Human BLCAP transcript: new editing events in normal and cancerous tissues. Int J Cancer (2010) 1.04
The fragile X protein binds mRNAs involved in cancer progression and modulates metastasis formation. EMBO Mol Med (2013) 0.99
Cellular responses to H(2)O(2) and bleomycin-induced oxidative stress in L6C5 rat myoblasts. Free Radic Biol Med (2003) 0.92
The Pro78 residue regulates the capacity of the human immunodeficiency virus type 1 Nef protein to inhibit recycling of major histocompatibility complex class I molecules in an SH3-independent manner. J Gen Virol (2006) 0.91
Vector-based RNA interference against vascular endothelial growth factor-A significantly limits vascularization and growth of prostate cancer in vivo. Cancer Gene Ther (2005) 0.91
Reelin affects chain-migration and differentiation of neural precursor cells. Mol Cell Neurosci (2009) 0.89
Body experiences, emotional competence, and psychosocial functioning in juvenile idiopathic arthritis. Rheumatol Int (2013) 0.89
A plasmid-encoded VEGF siRNA reduces glioblastoma angiogenesis and its combination with interleukin-4 blocks tumor growth in a xenograft mouse model. Cancer Biol Ther (2006) 0.87
The quality of life of children and adolescents with X-linked agammaglobulinemia. J Clin Immunol (2008) 0.87
CC chemokine ligand 2 down-modulation by selected Toll-like receptor agonist combinations contributes to T helper 1 polarization in human dendritic cells. Blood (2009) 0.86
Endocrine profiles and neuropsychologic correlates of functional hypothalamic amenorrhea in adolescents. Fertil Steril (2007) 0.86
A novel computational strategy to identify A-to-I RNA editing sites by RNA-Seq data: de novo detection in human spinal cord tissue. PLoS One (2012) 0.86
ADAR2 editing enzyme is a novel human immunodeficiency virus-1 proviral factor. J Gen Virol (2011) 0.85
Preadolescent anxiety: an epidemiological study concerning an Italian sample of 3,479 nine-year-old pupils. Child Psychiatry Hum Dev (2012) 0.85
ADAR enzyme and miRNA story: a nucleotide that can make the difference. Int J Mol Sci (2013) 0.84
RNA editing enters the limelight in cancer. Nat Med (2013) 0.84
AlphaB-crystallin is involved in oxidative stress protection determined by VEGF in skeletal myoblasts. Free Radic Biol Med (2010) 0.83
CoCl(2)-simulated hypoxia in skeletal muscle cell lines: Role of free radicals in gene up-regulation and induction of apoptosis. Free Radic Res (2007) 0.83
Thymic function and immunoglobulin mutation genotype in B-cell chronic lymphocytic leukemia patients. Int J Cancer (2003) 0.82
Paradoxical increase of plasma vitamin B12 and folates with disease severity in anorexia nervosa. Int J Eat Disord (2014) 0.81
ADARs and the Balance Game between Virus Infection and Innate Immune Cell Response. Curr Issues Mol Biol (2014) 0.81
Reduced fasting plasma levels of diazepam-binding inhibitor in adolescents with anorexia nervosa. Int J Eat Disord (2013) 0.81
The RNA editing enzymes ADARs: mechanism of action and human disease. Cell Tissue Res (2014) 0.81
Design and characterization of a chitosan physical gel promoting wound healing in mice. J Mater Sci Mater Med (2014) 0.80
Internalization and intracellular retention of CD4 are two separate functions of the human immunodeficiency virus type 1 Nef protein. J Gen Virol (2007) 0.80
Circulating miRNA profiling to identify biomarkers of dysmetabolism. Biomark Med (2012) 0.80
ADAR2 editing activity in newly diagnosed versus relapsed pediatric high-grade astrocytomas. BMC Cancer (2013) 0.79
Impact of speed and magnitude of weight loss on the development of brain trophic changes in adolescents with anorexia nervosa: a case control study. Ital J Pediatr (2013) 0.79
Interstitial 11q deletion: genomic characterization and neuropsychiatric follow up from early infancy to adolescence and literature review. BMC Res Notes (2014) 0.79
Feasibilty of in utero DNA vaccination following naked gene transfer into pig fetal muscle: transgene expression, immunity and safety. Vaccine (2005) 0.79
An anti-VEGF ribozyme embedded within the adenoviral VAI sequence inhibits glioblastoma cell angiogenic potential in vitro. J Vasc Res (2004) 0.79
Mathematical difficulties in nonverbal learning disability or co-morbid dyscalculia and dyslexia. Dev Neuropsychol (2013) 0.78
Body experiences and psychopathology in idiopathic central precocious and early puberty. Minerva Pediatr (2016) 0.77
Neuroligand binding endophenotypes in blood cells distinguish two subsets of borderline personality disorder patients. Neurosci Lett (2009) 0.77
Psychopathological traits of adolescents with functional hypothalamic amenorrhea: a comparison with anorexia nervosa. Eat Weight Disord (2013) 0.77
Autobiographical memory in adolescent girls with anorexia nervosa. Eur Eat Disord Rev (2014) 0.77
Detection of post-transcriptional RNA editing events. Methods Mol Biol (2015) 0.76
Peripheral medulloepithelioma: a rare tumor with a potential target therapy. J Transl Med (2014) 0.75
Hepatitis C virus therapeutics: editing enzymes promising therapeutic targets? Hepatology (2011) 0.75
Beta-amyloid plasma levels in adolescents with anorexia nervosa of the restrictive type. Neuropsychobiology (2015) 0.75
Fine-tuning of the binding and dissociation of CO by the amino acids of the heme pocket of Coprinus cinereus peroxidase. Biochemistry (2002) 0.75
Diazepam binding inhibitor and dehydroepiandrosterone sulphate plasma levels in borderline personality disorder adolescents. Neuropsychobiology (2013) 0.75
Body stalk anomaly: management of two dichorionic-diamniotic pregnancies. J Matern Fetal Neonatal Med (2008) 0.75